Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

724
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

807
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
807
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

4.1K
Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
4.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

614
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

631
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
631

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bench Brawn to Bedside Benefit: Sternal Closure Innovation.

The Annals of thoracic surgery·2026
Same author

Erratum to 'Trends, Predictors, and Outcomes of Temporary Mechanical Circulatory Support for Postcardiac Surgery Cardiogenic Shock' [The American Journal of Cardiology 123(2019) Pages 489-497].

The American journal of cardiology·2026
Same author

Comparative Estimation of Long-Term Graft Patency Rates After Isolated Coronary Artery Bypass Grafting: A Systematic Review and Meta-Analysis.

Cardiology in review·2025
Same author

Changes in ejection fraction after coronary artery bypass grafting for ischemic cardiomyopathy: Impact on survival and determinants of improvement.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Influence of effective orifice area on long-term survival in bioprosthetic versus mechanical aortic valves.

The Journal of thoracic and cardiovascular surgery·2025
Same author

Active and passive cardiac indexes as complementary predictors of outcomes after left ventricular assist device implantation.

The Journal of thoracic and cardiovascular surgery·2025
Same journal

Updated analysis of the Bronze Age population genetics from Bezdanjača Cave - the case of I2a1a male individuals.

Croatian medical journal·2026
Same journal

Systemic mesenchymal stem cell therapy for reduction of inflammatory burden in a patient with juvenile-onset rheumatoid arthritis and dialysis-dependent renal failure.

Croatian medical journal·2026
Same journal

Systemic metabolic, hormonal, and glycomic remodeling during a 72-hour fast in healthy adults: a pilot study.

Croatian medical journal·2026
Same journal

Artificial intelligence in pathology: a framework for preserving brain capital in the diagnostic apex.

Croatian medical journal·2026
Same journal

When algorithms testify: artificial intelligence-driven DNA analysis, evidentiary standards, and criminal justice reform.

Croatian medical journal·2026
Same journal

Artificial intelligence enables scale, consistency, and rigor in forensic identity inference.

Croatian medical journal·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K

Ventricular assist device selection: which one and when?

John M Stulak1, Ju Yong Lim, Simon Maltais

  • 1John M. Stulak, Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA, stulak.john@mayo.edu.

Croatian Medical Journal
|January 7, 2015
PubMed
Summary
This summary is machine-generated.

Mechanical circulatory support devices offer diverse options for heart failure patients. Advancements in ventricular assist devices promise improved outcomes and a brighter future for those with advanced heart failure.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K

Related Experiment Videos

Last Updated: Apr 19, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.8K
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

10.1K

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • Mechanical circulatory support (MCS) has revolutionized heart failure treatment.
  • Various devices provide short-, intermediate-, and long-term hemodynamic support.

Purpose of the Study:

  • To review the current landscape of MCS devices for heart failure.
  • To discuss factors influencing device selection and future trends.

Main Methods:

  • Review of current literature on mechanical circulatory support devices.
  • Analysis of device characteristics, clinical applications, and patient selection criteria.

Main Results:

  • A wide range of MCS devices are available, tailored to patient needs and support duration.
  • Device choice is influenced by clinical factors such as right heart function and multi-organ status.
  • Short-term ventricular assist devices (VADs) and timely hemodynamic support improve patient outcomes.

Conclusions:

  • MCS offers significant therapeutic options for acute and chronic heart failure.
  • Continued evolution of implantable VADs towards smaller, more durable designs enhances future prospects for advanced heart failure patients.